Related references
Note: Only part of the references are listed.The Structure-Based Design of Mdm2/Mdmx-p53 Inhibitors Gets Serious
Grzegorz M. Popowicz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures
Laura M. Salonen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Methyl-monofluorination of ibuprofen selectively increases its inhibitory activity toward cyclooxygenase-1 leading to enhanced analgesic activity and reduced gastric damage in vivo
Hong Su et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure
Angela D. Kerekes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The p53-MDM2/MDMX axis - A chemotype perspective
Kareem Khoury et al.
MEDCHEMCOMM (2011)
Robust Generation of Lead Compounds for Protein-Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists
Anna Czarna et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery
Grzegorz M. Popowicz et al.
CELL CYCLE (2010)
NMR-Based Screening of Membrane Protein Ligands
Naveena Yanamala et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, Virtual Space and p53-Mdm2 Activity
Yijun Huang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Ligand Entropy in Gas-Phase, Upon Solvation and Protein Complexation. Fast Estimation with Quasi-Newton Hessian
S. Wlodek et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Rapid and Efficient Hydrophilicity Tuning of p53/mdm2 Antagonists
Stuti Srivastava et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2009)
Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
Grzegorz M. Popowicz et al.
CELL CYCLE (2008)
Fluorine in medicinal chemistry
Sophie Purser et al.
CHEMICAL SOCIETY REVIEWS (2008)
Small molecular weight protein-protein interaction antagonists -: an insurmountable challenge?
Alexander Doemling
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Chemistry with [18F]fluoride ion
Lisheng Cai et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2008)
The many roles for fluorine in medicinal chemistry
William K. Hagmann
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Fluorine in pharmaceuticals:: Looking beyond intuition
Klaus Mueller et al.
SCIENCE (2007)
Predicting properties and tuning physicochemical in lead optimization:: Amine basicities
Martin Morgenthaler et al.
CHEMMEDCHEM (2007)
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit
Bradley J. Backes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Fluorine-18 and medical imaging: Radiopharmaceuticals for positron emission tomography
Didier Le Bars
JOURNAL OF FLUORINE CHEMISTRY (2006)
A critical assessment of docking programs and scoring functions
Gregory L. Warren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Modern synthetic methods for fluorine-substituted target molecules
M Shimizu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Fluorine in medicinal chemistry
HJ Böhm et al.
CHEMBIOCHEM (2004)
Application of NMR in structural proteomics: Screening for proteins amenable to structural analysis
T Rehm et al.
STRUCTURE (2002)
Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II
CY Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Metabolism of fluorine-containing drugs
BK Park et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Contribution of fluorine to protein-ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II
CY Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
